Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2006 2
2007 3
2008 4
2009 3
2010 2
2011 2
2012 2
2013 6
2014 4
2015 9
2016 7
2017 7
2018 7
2019 11
2020 7
2021 23
2022 23
2023 13
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Clinical research tools in pediatric oncology: challenges and opportunities.
de Rojas T, Neven A, Towbin AJ, Carceller F, Bautista F, Riedl D, Sodergren S, Darlington AS, Fernandez-Teijeiro A, Moreno L. de Rojas T, et al. Among authors: darlington as. Cancer Metastasis Rev. 2020 Mar;39(1):149-160. doi: 10.1007/s10555-020-09856-z. Cancer Metastasis Rev. 2020. PMID: 31939050 Free article. Review.
Development of feeding information for infants with CHD.
Marino LV, Johnson MJ, Davies NJ, Kidd C, Richens T, Bharucha T, Darlington AS. Marino LV, et al. Among authors: darlington as. Cardiol Young. 2019 Sep;29(9):1165-1171. doi: 10.1017/S1047951119001665. Epub 2019 Aug 5. Cardiol Young. 2019. PMID: 31379307 Review.
Paediatric palliative care.
Darlington AS, van den Heuvel-Eibrink MM, Passchier J. Darlington AS, et al. Lancet. 2008 Jun 28;371(9631):2169. doi: 10.1016/S0140-6736(08)60944-7. Lancet. 2008. PMID: 18586166 No abstract available.
Recommendations on the use of item libraries for patient-reported outcome measurement in oncology trials: findings from an international, multidisciplinary working group.
Piccinin C, Basch E, Bhatnagar V, Calvert M, Campbell A, Cella D, Cleeland CS, Coens C, Darlington AS, Dueck AC, Groenvold M, Herold R, King-Kallimanis BL, Kluetz PG, Kuliś D, O'Connor D, Oliver K, Pe M, Reeve BB, Reijneveld JC, Wang XS, Bottomley A. Piccinin C, et al. Among authors: darlington as. Lancet Oncol. 2023 Feb;24(2):e86-e95. doi: 10.1016/S1470-2045(22)00654-4. Lancet Oncol. 2023. PMID: 36725153 Review.
Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire.
van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI, Autran D, Hani HB, Chakrabarti M, Chinot O, Cho J, da Costa Vieira RA, Darlington AS, Debruyne PR, Dirven L, Doege D, Eller Y, Eichler M, Fridriksdottir N, Gioulbasanis I, Hammerlid E, van Hemelrijck M, Hermann S, Husson O, Jefford M, Johansen C, Kjaer TK, Kontogianni M, Lagergren P, Lidington E, Lisy K, Morag O, Nordin A, Al Omari ASH, Pace A, De Padova S, Petranovia D, Pinto M, Ramage J, Rammant E, Reijneveld J, Serpentini S, Sodergren S, Vassiliou V, Leeuw IV, Vistad I, Young T, Aaronson NK, van de Poll-Franse LV; EORTC QLG. van Leeuwen M, et al. Among authors: darlington as. J Cancer Surviv. 2023 Aug;17(4):1111-1130. doi: 10.1007/s11764-021-01160-1. Epub 2022 Jan 27. J Cancer Surviv. 2023. PMID: 35088246 Clinical Trial.
112 results